Nieuwe MDCG-richtsnoer ondersteunt ontwikkeling van diagnostische testen voor zeldzame aandoeningen
Safety Classified by Officially
The Medical Device Coordination Group (MDCG) has published new guidance on clinical evidence for so-called ‘orphan IVDs’. These diagnostic tests are intended for use in rare conditions or in exceptional clinical situations. The Federal Agency for Medicines and Health Products (FAMHP), together with the French ANSM, played a leading role in the development of this guidance. …
This is an extract. The publication continues at the source.
Read the original at the source: https://www.famhp.be/nl/news/nieuwe_mdcg_richtsnoer_ondersteunt_ontwikkeling_van_diagnostische_testen_voor_zeldzame
Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
- Official source
- https://www.famhp.be/en/rss.xml RSS
- Imported
- November 05, 2026 14:31
- Versions
- 1 recorded
- Identity
-
110437 at https://www.famhp.be